Carson Wealth (CWM LLC)
GTHX

Carson Wealth (CWM LLC)’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,500
Closed -$3K – 5256
2024
Q2 		$3K Hold
1,500
– – ﹤0.01% 4144
2024
Q1 		$6K Hold
1,500
– – ﹤0.01% 3621
2023
Q4 		$5K Hold
1,500
– – ﹤0.01% 3565
2023
Q3 		$2K Hold
1,500
– – ﹤0.01% 3891
2023
Q2 		$4K Hold
1,500
– – ﹤0.01% 3586
2023
Q1 		$4K Hold
1,500
– – ﹤0.01% 3448
2022
Q4 		$8K Hold
1,500
– – ﹤0.01% 2968
2022
Q3 		$19K Hold
1,500
– – ﹤0.01% 2275
2022
Q2 		$7K Hold
1,500
– – ﹤0.01% 2838
2022
Q1 		$11K Hold
1,500
– – ﹤0.01% 2454
2021
Q4 		$15K Buy
+1,500
New +$19.1K ﹤0.01% 2152

Carson Wealth (CWM LLC)'s GTHX Position: Q3 2024 in Review

Carson Wealth (CWM LLC) sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 1,500 shares — an estimated $3K sold.

Carson Wealth (CWM LLC) first reported a position in GTHX in Q4 2021 and held it in 11 quarters. The position peaked at $19K in Q3 2022. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

  • Carson Wealth (CWM LLC) reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 1,500 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $3K.
  • Carson Wealth (CWM LLC) first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • Carson Wealth (CWM LLC)'s G1 Therapeutics, Inc. Common Stock position peaked at $19K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2024, filed 8 Oct 2024.